Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Kymera Therapeutics, Inc. | StockGist | StockGist

Companies
KYMR
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings KYMRSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Kymera Therapeutics, Inc.

Filed Feb 10, 2026

Accepted Feb 10, 2026, 12:00 AM ET

CIK 0001815442

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Kymera Therapeutics, Inc.

Person Type

HC

CUSIP: 501575104

Recent Filings

Kymera Therapeutics, Inc.1 weeks ago

Kymera Therapeutics, Inc.1 months ago

Kymera Therapeutics, Inc.1 months ago

Kymera Therapeutics, Inc.1 months ago

Kymera Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice